Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 173 for:    Breast Cancer | Marseille, France

Institut Paoli Calmettes Breast Cancer Database

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02869607
Recruitment Status : Recruiting
First Posted : August 17, 2016
Last Update Posted : August 17, 2016
Sponsor:
Information provided by (Responsible Party):
Institut Paoli-Calmettes

Brief Summary:
Database of Institut Paoli-Calmettes patients diagnosed with breast cancer

Condition or disease Intervention/treatment
Breast Cancer Diagnosis Other: Data collection

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 45000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 10 Years
Official Title: Institut Paoli Calmettes Breast Cancer Database
Study Start Date : January 1995
Estimated Primary Completion Date : January 2030
Estimated Study Completion Date : December 2030

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer

Group/Cohort Intervention/treatment
Patients with breast cancer diagnosis Other: Data collection



Primary Outcome Measures :
  1. Survival of patients with breast cancer [ Time Frame: 10 years ]
    Overall survival of all patients who come in the center


Secondary Outcome Measures :
  1. Collection of patients characteristics [ Time Frame: 10 years ]
    Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with a diagnosis of Breat Cancer
Criteria

Inclusion Criteria:

  • Patient with a diagnosis of breast cancer

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02869607


Contacts
Layout table for location contacts
Contact: Dominique Genre, MD 0033491223778 drci.up@ipc.unicancer.fr
Contact: Lilian Laborde 0033491223778 labordel@ipc.unicancer.fr

Locations
Layout table for location information
France
Institut Paoli Calmettes Recruiting
Marseille, Bouches du Rhone, France, 13009
Contact: Dominique GENRE, MD    33 4 91 22 37 78    drci.up@ipc.unicancer.fr   
Sponsors and Collaborators
Institut Paoli-Calmettes
Additional Information:

Layout table for additonal information
Responsible Party: Institut Paoli-Calmettes
ClinicalTrials.gov Identifier: NCT02869607    
Other Study ID Numbers: BDD-SEIN-IPC
First Posted: August 17, 2016    Key Record Dates
Last Update Posted: August 17, 2016
Last Verified: August 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases